Biotechnology and Pharmaceuticals

September 21, 2020

Buy ($175)

Companies covered: Moderna (NASDAQ:MRNA), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Novavax, Inc. (NASDAQ:NVAX), Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), Vir Biotechnology (NASDAQ:VIR), Emergent Biosolutions, Inc. (NYSE:EBS), Oxford BioMedica plc (OTCMKTS:OXBDF), Luminex Corporation (NASDAQ:LMNX), Quidel Corporation (NASDAQ:QDEL), GlaxoSmithKline PLC (NYSE:GSK), AstraZeneca PLC (NASDAQ:AZN), Sanofi (NYSE:SNY), Pfizer, Inc. (NYSE:PFE), BioNTech SE (ADR) (NASDAQ:BNTX), Patterson Companies, Inc. (NASDAQ:PDCO), Henry Schein, Inc. (NASDAQ:HSIC), Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), Johnson & Johnson (NYSE:JNJ), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Endo International plc (NASDAQ:ENDP), Eli Lilly and Company (NYSE:LLY), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Zoetis Inc. (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Merck & Company, Inc. (NYSE:MRK), Amazon.com, Inc. (NASDAQ:AMZN), Covetrus (NASDAQ:CVET), Chewy (NYSE:CHWY), Abivax (OTCMKTS:AAVXF), Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR), Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), Fate Therapeutics, Inc. (NASDAQ:FATE), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Epizyme, Inc. (NASDAQ:EPZM), Blueprint Medicines Corp. (NASDAQ:BPMC), Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), Novartis AG (NYSE:NVS), Beam Therapeutics (NASDAQ:BEAM), Generation Bio Co. (NASDAQ:GBIO), SpringWorks Therapeutics (NASDAQ:SWTX), Argenx SE (ADR) (NASDAQ:ARGX), Gilead Sciences, Inc. (NASDAQ:GILD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Immunomedics, Inc. (NASDAQ:IMMU), aTyr Pharma (NASDAQ:LIFE), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), NeuBase Therapeutics, Inc. (NASDAQ:NBSE), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Wave Life Sciences Ltd (NASDAQ:WVE), Catabasis Pharmaceuticals Inc (NASDAQ:CATB), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), AbbVie Inc. (NYSE:ABBV), Bristol-Myers Squibb Company (NYSE:BMY), Seelos Therapeutics, Inc. (NASDAQ:SEEL), Kazia Therapeutics Limited (NASDAQ:KZIA), Akebia Therapeutics, Inc. (NASDAQ:AKBA), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), 22nd Century Group, Inc. (NYSEAMERICAN:XXII), EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), Boomer Holdings, Inc. (OTCMKTS:BOMH)